Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Argenx Se ADR (NQ: ARGX )

279.25 USD -2.23 (-0.79%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 185,686
Open 280.95
Bid (Size) 279.14 (6)
Ask (Size) 279.74 (3)
Prev. Close 281.48
Today's Range 276.93 - 282.95
52wk Range 248.21 - 382.15
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
argenx Announces VYVGART™ Approval in Japan for the Treatment of Generalized Myasthenia Gravis
argenx Announces VYVGART™ Approval in Japan for the Treatment of Generalized Myasthenia Gravis 
From Business Wire News Releases
argenx Highlights Strategic Priorities for 2022
argenx Highlights Strategic Priorities for 2022 
From Business Wire News Releases

Performance

YTD
-20.46%
-20.46%
1 Month
-20.12%
-20.12%
3 Month
-4.74%
-4.74%
6 Month
-11.65%
-11.65%
1 Year
-11.43%
-11.43%

More News

Read More
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
Tags Penny Stocks General FDA
From Benzinga
What 8 Analyst Ratings Have To Say About argenx
Tags Benzinga Analyst Ratings Market News
From Benzinga
argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis
From Business Wire News Releases
What 8 Analyst Ratings Have To Say About argenx
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
Argenx's Vyvgart Wins FDA Approval For Autoimmune, Neuromuscular Disease
Tags why it's moving ARGX Benzinga
From Benzinga
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 4%
Tags LW Futures CCL
From Benzinga
5 Stocks To Watch For December 20, 2021
Tags ARGX Pre/Market Outlook Benzinga
From Benzinga
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
Tags Biotech Benzinga JPM
From Benzinga
Is Argenx a Good Biotech Stock to Buy for 2022?
Tags Market News Recent Press Releases AZN
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.